Bloomberg on MSN1mon
Bristol Raises Guidance on Demand for Eliquis, New Drugs(Bloomberg) -- Bristol Myers Squibb Co. raised its 2024 earnings guidance after reporting better-than-expected revenue and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback